| 2009 |
POLD4 is required for full in vitro DNA synthesis activity of pol δ; pol δ lacking POLD4 shows reduced activity regardless of whether the processivity factor PCNA is present. |
In vitro DNA polymerase activity assay with and without POLD4, with and without PCNA |
Biochemical and biophysical research communications |
Medium |
19931513
|
| 2009 |
shRNA-mediated reduction of POLD4 in lung cancer cells results in increased karyomere-like cells (indicative of replication stress/DNA damage) and reduced colony formation, establishing a role for POLD4 in cell proliferation and genomic stability maintenance. |
shRNA knockdown, colony formation assay, cell morphology analysis |
Biochemical and biophysical research communications |
Medium |
19931513
|
| 2010 |
siRNA-mediated reduction of POLD4 causes cell cycle delay, checkpoint activation, and elevated chromosomal gap/break frequency; rescue by siRNA-resistant POLD4 confirmed these effects are specifically due to POLD4 loss. POLD4 overexpression reduced γ-H2AX induction, further linking POLD4 to DNA double-strand break suppression. |
siRNA knockdown, rescue with siRNA-resistant POLD4 construct, cell cycle analysis, γ-H2AX immunofluorescence, chromosomal gap/break scoring |
Cancer research |
High |
20861182
|
| 2010 |
In vitro, pol δ exhibits impaired DNA synthesis activity in the absence of POLD4, confirming POLD4 as a stimulatory subunit of the pol δ complex. |
In vitro DNA synthesis assay with pol δ complexes with/without POLD4 |
Cancer research |
Medium |
19931513 20861182
|
| 2014 |
POLD4 knockdown in Calu6 lung cancer cells suppresses the Akt-Skp2-p27 signaling pathway: reduced POLD4 leads to decreased phospho-Akt (Ser473) and Skp2 and increased p27, causing G1-S cell cycle blockage. Rescue with siRNA-resistant POLD4 restored these protein expression levels. |
siRNA knockdown, rescue with siRNA-resistant POLD4, western blot for p-Akt, Skp2, p27, cell cycle analysis |
Bioorganic & medicinal chemistry letters |
Medium |
24618301
|
| 2016 |
POLD4 protein levels in A549 cells decrease following treatment with the carcinogen 4-nitroquinoline-1-oxide (4NQO), and this decrease is reversed by MG132, a proteasome inhibitor, indicating that 4NQO-induced POLD4 downregulation occurs via proteasomal degradation. |
Western blot with/without MG132 proteasome inhibitor treatment |
Biomedical reports |
Medium |
26998273
|
| 2021 |
In chicken DT40 cells, POLD4 deletion increases the rate and tract length of IgV gene conversion (HR-mediated), altering pseudo-V segment usage, without affecting general HR (sister chromatid exchange or gene targeting at I-SceI-induced DSBs). This places POLD4 as a suppressor of replication-associated HR gene conversion specifically. |
POLD4 knockout cells, IgV gene conversion assay, sister-chromatid exchange assay, I-SceI-induced gene targeting assay |
DNA repair |
High |
33588156
|
| 2022 |
X-ray crystal structure of the N-terminal PIP motif of Chaetomium thermophilum PolD4 (ortholog of human POLD4/p12) bound to PCNA at 2.45 Å resolution reveals non-canonical binding: the PIP motif lacks the typical 310 helix and instead uses a conserved glutamine inserted into the Q-pocket and conserved leucine/phenylalanine in a compact 2-fork plug to engage the PCNA hydrophobic pocket. ITC confirms similar affinity to human p12. |
X-ray crystallography (2.45 Å), isothermal calorimetry (ITC) |
The FEBS journal |
High |
35942639
|
| 2022 |
Pold4 knockout mice are viable and fertile with no detectable pathological changes; knockout mouse fibroblasts show normal cell growth, cell cycle, DNA replication, and DNA damage/repair capacity, indicating that the trimeric pol δ3 (lacking POLD4) is sufficient for these processes in normal mammalian cells. |
Pold4 knockout mouse model, histopathology, cell growth assay, cell cycle analysis, DNA replication and repair assays in tail-tip fibroblasts |
Gene |
Medium |
36356905
|
| 2024 |
UCHL3, a deubiquitinase in the UCH protease family, directly interacts with POLD4, depolyubiquitinates it, and thereby stabilizes POLD4 protein in glioma stem cells. Loss of the UCHL3-POLD4 axis impairs homologous recombination and non-homologous end joining, reducing GSC self-renewal, tumorigenic capacity, and ionizing radiation resistance. |
Co-immunoprecipitation, GST pull-down, ubiquitination assay, intracranial xenograft mouse model, HR/NHEJ reporter assays |
Cellular and molecular life sciences : CMLS |
High |
38829550
|
| 2024 |
Pold4 promotes fork reversal during lagging-strand replication encountering single-strand breaks: POLD4-/- cells show selective sensitivity to camptothecin (a topoisomerase I inhibitor that generates SSBs during replication). Epistasis analysis using PARP1-/-, POLD4-/-, POLE1exo-/- and double-KO cells placed Pold4 in the PARP1-Polε exonuclease-mediated fork reversal pathway, suppressing DSBs arising from lagging-strand stalling on broken templates. |
POLD4 knockout DT40 cells, camptothecin and other DNA-damaging agent sensitivity assays, genetic epistasis with PARP1-/- and POLE1exo-/- double knockouts |
DNA repair |
High |
38678695
|
| 2024 |
Depletion or deletion of POLD4 significantly inhibits DSB-induced large-scale genomic amplification (DIGA) in human cancer cells, placing POLD4 as a component of the break-induced replication (BIR) machinery mediating conservative DNA synthesis-driven genomic amplification. |
POLD4 depletion/deletion, DIGA quantification following IR and DSB-inducing agents, genetic interaction with POLD3 and RAD52 |
bioRxivpreprint |
Medium |
bio_10.1101_2024.08.27.609980
|